LeonaBio Ord Shs
LONA4.655USD
+0.075+1.64%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
18.36MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Unternehmen
LeonaBio Ord Shs Informationen
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von LeonaBio Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
42.80K
-2586.00%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
20.68K
-876.00%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
13.98K
-876.00%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
12.86K
-297.00%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
10.19K
-1644.00%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-2419.00%
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Independent Director
Independent Director
2.58K
--
James A. Johnson ,
James A. Johnson ,
Independent Director
Independent Director
500.00
--
Ms. Barbara Kosacz, J.D.
Ms. Barbara Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
42.80K
-2586.00%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
20.68K
-876.00%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
13.98K
-876.00%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
12.86K
-297.00%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
10.19K
-1644.00%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-2419.00%
Umsatzaufteilung
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Tue, Jan 13
Aktualisiert: Tue, Jan 13
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Perceptive Advisors LLC
47.14%
Acorn Capital Advisors, LLC
15.11%
Simplify Asset Management Inc
7.57%
Baselake Management, LLC
5.63%
Nemean Asset Management, LLC
4.09%
Andere
20.45%
Aktionäre
Aktionäre
Anteil
Perceptive Advisors LLC
47.14%
Acorn Capital Advisors, LLC
15.11%
Simplify Asset Management Inc
7.57%
Baselake Management, LLC
5.63%
Nemean Asset Management, LLC
4.09%
Andere
20.45%
Aktionärstypen
Aktionäre
Anteil
Private Equity
47.40%
Investment Advisor
28.70%
Corporation
9.73%
Individual Investor
4.14%
Hedge Fund
4.09%
Venture Capital
3.79%
Investment Advisor/Hedge Fund
2.15%
Family Office
0.98%
Research Firm
0.83%
Institutionelle Beteiligung
Aktualisiert: Tue, Jan 13
Aktualisiert: Tue, Jan 13
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
107
3.43M
86.99%
+588.35K
2025Q4
113
3.34M
84.61%
+1.00M
2025Q3
123
1.85M
47.14%
-805.95K
2025Q2
137
1.88M
48.34%
-780.64K
2025Q1
169
1.88M
48.36%
-912.05K
2024Q4
181
1.93M
49.87%
-1.07M
2024Q3
198
1.93M
50.33%
-1.16M
2024Q2
215
2.54M
66.42%
-582.38K
2024Q1
233
2.49M
65.12%
-1.23M
2023Q4
240
2.51M
65.92%
-1.08M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Perceptive Advisors LLC
1.86M
47.14%
+1.32M
+244.13%
Dec 23, 2025
Acorn Capital Advisors, LLC
501.74K
12.72%
+501.74K
--
Dec 22, 2025
Simplify Asset Management Inc
298.56K
7.57%
--
--
Sep 30, 2025
Baselake Management, LLC
222.22K
5.63%
+222.22K
--
Nov 07, 2025
Nemean Asset Management, LLC
161.22K
4.09%
-38.25K
-19.17%
Oct 01, 2025
The Vanguard Group, Inc.
153.79K
3.9%
-2.00
-0.00%
Sep 30, 2025
Propel Bio Management, LLC
149.28K
3.79%
+149.28K
--
Dec 31, 2025
Tang Capital Management, LLC
60.00K
1.52%
-2.00
-0.00%
Sep 30, 2025
Renaissance Technologies LLC
51.92K
1.32%
+27.82K
+115.45%
Sep 30, 2025
Litton (Mark James)
45.38K
1.15%
+10.83K
+31.36%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Jan 13
Aktualisiert: Tue, Jan 13
Name
Anteil
Simplify Propel Opportunities ETF
1.54%
Dimensional US Core Equity 1 ETF
0%
iShares US Small-Cap Equity Factor ETF
0%
iShares Micro-Cap ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Neuroscience and Healthcare ETF
0%
Avantis US Small Cap Equity ETF
0%
Simplify Propel Opportunities ETF
Anteil1.54%
Dimensional US Core Equity 1 ETF
Anteil0%
iShares US Small-Cap Equity Factor ETF
Anteil0%
iShares Micro-Cap ETF
Anteil0%
DFA Dimensional US Sustainability Core 1 ETF
Anteil0%
iShares Neuroscience and Healthcare ETF
Anteil0%
Avantis US Small Cap Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
